Delivery Order SPE2DB24D2109-SPE2DB25FHXYF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,040.59 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count packages) on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is a neurological medication used as an adjunctive treatment for epilepsy and seizure...
- The Defense Logistics Agency awarded a $1,604.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitive award, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a $4,169.69 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 6 mg tablets (30-count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 mg tablets (30-count units) valued at $2,094.26 on September 23, 2025, with completion scheduled for September 24, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed through AmerisourceBergen's existing contract vehicle with DLA. FYCOMPA (perampanel) is an oral antiepileptic medication used as adjunctive therapy for partial-onset seizures and primary...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,965.36 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 2 mg tablets (30-count units) on May 30, 2025, with a completion date of June 2, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for FYCOMPA 4 mg tablets (30-count package) with a ceiling value of $2,067.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 24, 2025, and the place of performance is located in Conshohocken, PA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,049.88 to AmerisourceBergen Drug Corp for FYCOMPA (perampanel) 10 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania. FYCOMPA is an oral anticonvulsant medication used as adjunctive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of FYCOMPA 4 mg tablets (30-count units) with a ceiling value of $3,134.37. This firm fixed-price delivery order, which has an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,027.44 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count) on August 14, 2025, with completion targeted for August 15, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.38 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count units) under a firm fixed price contract. The award was made on July 15, 2025, with an ultimate completion date of July 16, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXYFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 MG tablets (30-count supply) valued at $1,752.54 under a firm fixed price contract type. The delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. FYCOMPA (perampanel) is a neurological medication used for seizure management, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products and medical supplies supporting federal healthcare systems, including the Defense Health Agency and military treatment facilities. As a major pharmaceutical distributor, AmerisourceBergen maintains significant capacity to fulfill diverse medical procurement requirements across therapeutic domains on behalf of the Department of Defense and federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/23/25 |